Mitsui Chemicals, Kemira in Agreement For Acrylamide Bio-Process Technology

:: 28 Jan  2013 ::

Tokyo- Mitsui Chemicals said it has signed a licensing agreement with Kemira giving Kemira “geographical exclusivity” for the production of acrylamide (AAM) using Mitsui’s proprietary bio-process technology.

Mitsui noted that its AAM manufacturing technology, which uses bio-catalysts, has been “highly evaluated for its stability in producing high-quality products, when compared with existing copper catalyst chemical processes, and its low burden on the environment.”

Separately, Kemira said it has completed a two-year, multi-million euro expansion of its North American polymer production facilities, and added that the agreement with Mitsui will strengthen its polymer product line globally.  The expansion resulted in a 60% capacity increase.

More stories from Petrochemical News